Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1233 of 5804
-
New heart ablation technique could tame dangerous rhythms in adults born with heart defects
Disease control TerminatedThis is a prospective, single-arm intervention trial whereby we will test the safety and efficacy of performing pulmonary vein isolation (PVI) using pulsed field ablation (PFA) in adult patients with congenital heart disease (CHD) who are presenting for atrial tachycardia (AT) ab…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New hope for teens with HIV: counseling program aims to reduce suicide risk
Disease control Recruiting nowThe overall aim of this study is to determine the feasibility, fidelity, acceptability, and preliminary effectiveness of the Friendship Bench +Safety Planning intervention in reducing suicidal ideation and behaviors (SIBs) and improving HIV engagement amongst adolescents living w…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New insulin algorithm aims to tame type 2 diabetes
Disease control CompletedThe purpose of the study is to assess the safety and efficacy of a next generation automated insulin delivery algorithm in adults with type 2 diabetes aged 16-70 years old
Phase: NA • Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Promising combo targets tough esophageal cancer in small trial
Disease control Recruiting nowIn the era of immunotherapy, the standard second-line treatment regimen for locally advanced/metastatic esophageal squamous cell carcinoma (ESCC) remains controversial. This prospective, single-center, single-arm phase II clinical study aims to evaluate the efficacy and safety of…
Phase: PHASE2 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can acupuncture with electricity lift mood in cancer patients?
Symptom relief Recruiting nowCancer-related depression (CRD) is a common psychological condition among cancer patients during diagnosis, treatment, and recovery, and is associated with reduced quality of life, impaired immune function, and poorer clinical outcomes. As cancer incidence and mortality continue …
Phase: NA • Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Could a malaria drug boost leukemia treatment?
Disease control OngoingChronic myeloid leukaemia (CML) is a blood cancer with an annual worldwide incidence of 1/100,000 population. Imatinib is used for the treatment of CML and has significantly improved the management of the disease. However, the incidence of treatment failure due to imatinib resist…
Phase: PHASE2 • Sponsor: Obafemi Awolowo University • Aim: Disease control
Last updated Jun 26, 2026 14:03 UTC
-
Brain zaps for young minds: can TMS ease anxiety and depression?
Symptom relief Recruiting nowIn this open-label trial, the overall aim is to determine if TMS treatment can improve anxiety and depression in a broad group of children and youth referred by physicians.
Phase: NA • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
AI boosts colonoscopy accuracy to prevent advanced polyps
Disease control Recruiting nowThe goal of this prospective study is to to evaluate the prevalence of metachronous advanced colonic lesions in subsequent surveillance colonoscopies in patients who had previously undergone AI-assisted colonoscopy to conventional colonoscopy examinations. The main question it a…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can exercise and music beat dementia? a new study targets At-Risk veterans
Disease control Recruiting nowThis study will begin to evaluate personalized preventative dementia treatments for Veterans at risk for developing dementia. The investigators will target Veterans with Motoric Cognitive Risk syndrome (MCR), which is characterized by slow gait speed and cognitive concerns (e.g.,…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Hospital ventilator orders get a brain boost to prevent lung damage
Disease control Recruiting nowThis study is a cluster randomized trial across 10 hospitals, stratified by hospital size (hospitals with greater than 100 mechanically ventilated patients a year will be classified as large, while those with 100 or fewer will be classified as small). Randomization will occur at …
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could a liver drug help kids and adults with rare metabolic disorder?
Disease control Recruiting nowThis is a medical research study to test a medication in patients 4 years of age and older with a disease called medium-chain acyl-CoA dehydrogenase deficiency (MCADD) caused by the common ACADM c.985 A\>G (K304E) mutation. The medication is sodium phenylbutyrate (ACER-001), whic…
Phase: PHASE2 • Sponsor: Jerry Vockley, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Robot vs. transanal surgery: which is better for low rectal cancer?
Disease control Recruiting nowTME remains standard treatment for rectal cancer. Both Robotic TME and taTME are innovative surgical techniques with potential advantages in low rectal cancer. To date, no clinical studies have directly compared the conversion and complication rates between taTME and RTME in this…
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New obesity drug GV101 shows promise in Mid-Stage trial
Disease control CompletedThe purpose of this trial is to evaluate the efficacy and safety of GV101 for weight loss over a range of doses in participants with obesity. The primary efficacy endpoint is the mean percent change in body weight from baseline at Week 16 in each treated group as compared with pl…
Phase: PHASE2 • Sponsor: Graviton Bioscience Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope for mesothelioma: drug targets cancer from two angles
Disease control Recruiting nowMulticentre, open-label, single arm phase II study for patients with PM previously treated by immunotherapy and standard chemotherapy. 38 patients will be given second or third-line treatment with ivonescimab 20mg/kg every 3 weeks. An estimated 38 patients will be enrolled in ap…
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New rapid test could slash ER wait times for chest pain patients
Diagnosis Recruiting nowThe goal of this study is to evaluate whether a POC-guided testing strategy to exclude non-ST elevation myocardial infarction (NSTEMI) in acute chest pain patients presenting at the emergency department (ED) can result in a shorter length of stay compared to the routine central l…
Phase: NA • Sponsor: KU Leuven • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
New chemo cocktail targets rare small bowel tumors
Disease control Recruiting nowThe study regimen will be administered on an outpatient basis and all medications are administered intravenously (IV). Subjects will receive treatment on Day 1 and Day 15 of each 28-day cycle consisting of the following: nanoliposomal irinotecan at 50 mg/m2, followed by oxaliplat…
Phase: PHASE2 • Sponsor: Tiago Biachi de Castria • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug aims to reverse heart damage in failure patients
Disease control Recruiting nowThis study will look into how CDR132L (a potential new medicine) works on the structure and function of the heart in people living with heart failure. Participants will either get CDR132L or placebo (a medicine which has no effect on the body), which treatment the participants ge…
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New hope for rare lung infection: weekly drug shows promise in early trial
Disease control OngoingThe goal of this clinical trial is to to evaluate the drug rezafungin in the treatment of Chronic Pulmonary Aspergillosis (CPA) in male and female patients aged 18 years and over with limited treatment options. The study aims to answer whether 6 months of rezafungin treatment is…
Phase: PHASE2 • Sponsor: Mundipharma Research Limited • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Lupus drug belimumab may shield organs from damage, new study hopes to prove
Disease control Recruiting nowThis will be a combined retrospective and prospective cohort study, that will evaluate the incidence of de novo Systemic Lupus Erythematosus major organ manifestations (defined as BILAG A flares) in patients receiving belimumab (Arm A) and compare it to 2 standard-of-care groups …
Sponsor: Biomedical Research Foundation, Academy of Athens • Aim: Disease control
Last updated Jun 26, 2026 14:41 UTC
-
New shot aims to ease neck pain for months longer
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of the study drug, IPN10200, and to assess how well it works when compared with placebo in treating Cervical Dystonia (CD) in adults. CD can cause a series of abnormalities and symptoms in the head and neck that ca…
Phase: PHASE2 • Sponsor: Ipsen • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC